Immunofocusing humoral immunity potentiates the functional efficacy of the AnAPN1 malaria transmission-blocking vaccine antigen
Abstract Malaria transmission-blocking vaccines (TBVs) prevent the completion of the developmental lifecycle of malarial parasites within the mosquito vector, effectively blocking subsequent infections. The mosquito midgut protein Anopheline alanyl aminopeptidase N (AnAPN1) is the leading, mosquito-...
Main Authors: | Nicole G. Bender, Prachi Khare, Juan Martinez, Rebecca E. Tweedell, Vincent O. Nyasembe, Borja López-Gutiérrez, Abhai Tripathi, Dustin Miller, Timothy Hamerly, Eric M. Vela, Ryan R. Davis, Randall F. Howard, Sandrine Nsango, Ronald R. Cobb, Matthias Harbers, Rhoel R. Dinglasan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-021-00309-4 |
Similar Items
-
NPC1161B, an 8-Aminoquinoline Analog, Is Metabolized in the Mosquito and Inhibits Plasmodium falciparum Oocyst Maturation
by: Timothy Hamerly, et al.
Published: (2019-10-01) -
Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45
by: Michael Pritsch, et al.
Published: (2016-01-01) -
Protein O-Fucosyltransferase 2 Is Not Essential for Plasmodium berghei Development
by: Silvia Sanz, et al.
Published: (2019-07-01) -
Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing.
by: Michael Humbert, et al.
Published: (2008-01-01) -
Development of immunofocusing virus-like particles as broadly protective influenza vaccines
by: Liu Ying Yu, et al.
Published: (2016)